Abbott Laboratories (ABT) NYSE
108.60
-2.11(-1.91%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
108.60
-2.11(-1.91%)
Currency In USD
| Market Cap | 218.88B |
| Enterprise Value | 225.43B |
| P/E Ratio | 28.95 |
| PEG Ratio | -0.54 |
| Price/Sales Ratio | 4.24 |
| Price/Book Ratio | 3.62 |
| Enterprise/Revenue | 4.4 |
| Enterprise/EBITDA | 16.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
| Return On Assets | 0.08 |
| Return On Equity | 0.13 |
| Revenue | 44.33B |
| Revenue/Share | 25.37 |
| Gross Profit | 24.61B |
| EBITDA | 11.55B |
| Net Income | 6.52B |
| Diluted EPS | 3.72 |
| Total Cash | 8.94B |
| Total Cash/Share | 5.12 |
| Total Debt | 15.07B |
| Total Debt/Equity | 0.29 |
| Current Ratio | 1.58 |
| Book Value Per Share | 30.21 |
| 52-Week Change | -14.01 |
| 52-Week High | 139.06 |
| 52-Week Low | 105.27 |
| Moving Average 50 Days | 114.31 |
| Moving Average 200 Days | 126.08 |
| Average Volume | 9.75M |
| Shares Outstanding | 1.74B |
| % Held by Institutions | 81.83 |
| Trailing Annual Dividend Rate | 2.4 |
| Trailing Annual Dividend Yield | 2.22 |
| Payout Ratio | 0.63 |
| Last Split Factor | 5000:2399 |
| Last Split Date | January 02, 2013 |